Multiple Sclerosis (MS) is a neurodegenerative autoimmune disorder of the central nervous
system (CNS) characterized by the recruitment of self-reactive T lymphocytes, mainly …

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system
(CNS) characterized by destruction of the myelin sheath structure. The loss of myelin leads …

CD8+ T cells outnumber CD4+ cells in multiple sclerosis (MS) lesions associated with
disease progression, but the pathogenic role and antigenic targets of these clonally …

The runt-related transcription factor-1 (RUNX1) gene with its lncRNA RUNXOR are recently
becoming a research focus in various diseases, specifically immune-related diseases as …

Multiple sclerosis is associated with Epstein–Barr virus (EBV) infection, B‐cell dysfunction,
gut dysbiosis, and environmental and genetic risk factors, including female sex. A disease …

Over the past decade, multiple sclerosis (MS), a chronic neuroinflammatory disease with
severe personal and social consequences, has undergone a steady increase in incidence …

Biological aging is the strongest factor associated with the clinical phenotype of multiple
sclerosis (MS). Relapsing-remitting MS typically presents in the third or fourth decade …

Multiple Sclerosis (MS) is a chronic, inflammatory demyelinating disease of the central
nervous system (CNS) driven by a complex interplay of genetic and environmental factors …

Although typically associated with onset in young adults, multiple sclerosis (MS) also attacks
the elderly, which is termed late‐onset MS. The disease can be recapitulated and studied in …

The induction of specific immunological tolerance represents an important therapeutic goal
for multiple sclerosis and other autoimmune diseases. Sound knowledge of the target …